Clinical Trial Update: Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating an autologous tumor DRibble vaccine in patients with Non-Small Cell Lung Cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Autologous Tumor DRibble Vaccine

Snippet

Sponsor: Providence Health & Services | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED